Human GPC3(Glypican 3) ELISA Kit
To Order Contact us: [email protected]
Human Glypican 3 (GPC3) ELISA Kit |
|||
RD-GPC3-Hu-48Tests | Reddot Biotech | 48 Tests | 573.6 EUR |
Human Glypican 3 (GPC3) ELISA Kit |
|||
RD-GPC3-Hu-96Tests | Reddot Biotech | 96 Tests | 794.4 EUR |
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
DLR-GPC3-Mu-48T | DL Develop | 48T | 586.8 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Glypican 3 (GPC3) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
DLR-GPC3-Mu-96T | DL Develop | 96T | 762 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Glypican 3 (GPC3) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Rat Glypican 3 (GPC3) ELISA Kit |
|||
DLR-GPC3-Ra-48T | DL Develop | 48T | 609.6 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Glypican 3 (GPC3) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Rat Glypican 3 (GPC3) ELISA Kit |
|||
DLR-GPC3-Ra-96T | DL Develop | 96T | 793.2 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Glypican 3 (GPC3) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
RDR-GPC3-Mu-48Tests | Reddot Biotech | 48 Tests | 613.2 EUR |
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
RDR-GPC3-Mu-96Tests | Reddot Biotech | 96 Tests | 850.8 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
RDR-GPC3-Ra-48Tests | Reddot Biotech | 48 Tests | 640.8 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
RDR-GPC3-Ra-96Tests | Reddot Biotech | 96 Tests | 890.4 EUR |
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
RD-GPC3-Mu-48Tests | Reddot Biotech | 48 Tests | 586.8 EUR |
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
RD-GPC3-Mu-96Tests | Reddot Biotech | 96 Tests | 812.4 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
RD-GPC3-Ra-48Tests | Reddot Biotech | 48 Tests | 613.2 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
RD-GPC3-Ra-96Tests | Reddot Biotech | 96 Tests | 850.8 EUR |
Human Glypican 3 (GPC3) ELISA Kit |
|||
20-abx151694 | Abbexa |
|
|
Human Glypican 3 (GPC3) ELISA Kit |
|||
abx051686-96tests | Abbexa | 96 tests | 848.4 EUR |
Human Glypican 3 (GPC3) ELISA Kit |
|||
abx250341-96tests | Abbexa | 96 tests | 848.4 EUR |
Human GPC3(Glypican-3) ELISA Kit |
|||
EH1096 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
|||
Human GPC3/ Glypican-3 ELISA Kit |
|||
E1045Hu | Sunlong | 1 Kit | 685.2 EUR |
Human Glypican 3(GPC3)ELISA Kit |
|||
GA-E1448HM-48T | GenAsia Biotech | 48T | 346.8 EUR |
Human Glypican 3(GPC3)ELISA Kit |
|||
GA-E1448HM-96T | GenAsia Biotech | 96T | 559.2 EUR |
Human Glypican- 3, GPC3 ELISA KIT |
|||
ELI-03142h | Lifescience Market | 96 Tests | 988.8 EUR |
Human Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5128.02 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 527.48 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 702.12 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 2799.54 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Glypican 3 (GPC3) ELISA Kit |
|||
4-SEA971Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Glypican 3 (GPC3) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Glypican 3 ELISA Kit (GPC3) |
|||
RK01492 | Abclonal | 96 Tests | 625.2 EUR |
Human Glypican 3(GPC3)ELISA Kit |
|||
QY-E02277 | Qayee Biotechnology | 96T | 433.2 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
20-abx155595 | Abbexa |
|
|
Monkey Glypican 3 (GPC3) ELISA Kit |
|||
abx359073-96tests | Abbexa | 96 tests | 990 EUR |
Pig Glypican 3 (GPC3) ELISA Kit |
|||
abx360627-96tests | Abbexa | 96 tests | 990 EUR |
Rabbit Glypican 3 (GPC3) ELISA Kit |
|||
abx362738-96tests | Abbexa | 96 tests | 990 EUR |
Sheep Glypican 3 (GPC3) ELISA Kit |
|||
abx364415-96tests | Abbexa | 96 tests | 1111.2 EUR |
Mouse Glypican 3 (GPC3) ELISA Kit |
|||
abx254136-96tests | Abbexa | 96 tests | 848.4 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
abx255680-96tests | Abbexa | 96 tests | 848.4 EUR |
Chicken Glypican 3 (GPC3) ELISA Kit |
|||
abx356317-96tests | Abbexa | 96 tests | 990 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
abx571478-96tests | Abbexa | 96 tests | 848.4 EUR |
Rat Glypican-3(GPC3) ELISA kit |
|||
CSB-EL009705RA-24T | Cusabio | 1 plate of 24 wells | 198 EUR |
Description: Quantitativesandwich ELISA kit for measuring Rat Glypican-3 (GPC3) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Rat Glypican-3(GPC3) ELISA kit |
|||
1-CSB-EL009705RA | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Rat Glypican-3(GPC3) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Rat GPC3(Glypican 3) ELISA Kit |
|||
ER1007 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.094 ng/ml |
|||
Mouse GPC3(Glypican 3) ELISA Kit |
|||
EM1084 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.094 ng/ml |
|||
Mouse Glypican- 3, Gpc3 ELISA KIT |
|||
ELI-03140m | Lifescience Market | 96 Tests | 1038 EUR |
Rat Glypican- 3, Gpc3 ELISA KIT |
|||
ELI-03141r | Lifescience Market | 96 Tests | 1063.2 EUR |
Rat Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Ra-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5552.14 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Ra-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 562.42 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Ra-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 752.02 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Glypican 3 (GPC3) ELISA Kit |
|||
SEA971Ra-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3024.07 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Glypican 3 (GPC3) ELISA Kit |
|||
4-SEA971Ra | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Glypican 3 (GPC3) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Rat Glypican 3 ELISA Kit (GPC3) |
|||
RK03695 | Abclonal | 96 Tests | 625.2 EUR |
ELISA kit for Human GPC3 (Glypican 3) |
|||
ELK2141 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Glypican 3 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
ELISA kit for Human Glypican-3 (GPC3) |
|||
KTE62925-48T | Abbkine | 48T | 424.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Glypican-3 (GPC3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Glypican-3 (GPC3) |
|||
KTE62925-5platesof96wells | Abbkine | 5 plates of 96 wells | 2702.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Glypican-3 (GPC3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Glypican-3 (GPC3) |
|||
KTE62925-96T | Abbkine | 96T | 686.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Glypican-3 (GPC3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human GPC3 (Glypican 3) |
|||
E-EL-H1712 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Human GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
|||
Human Glypican 3 (GPC3) CLIA Kit |
|||
abx195535-96tests | Abbexa | 96 tests | 990 EUR |
Human Glypican 3 (GPC3) CLIA Kit |
|||
20-abx492279 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx100556 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx001589 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx125892 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx125893 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx112820 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx129737 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
abx015875-100ug | Abbexa | 100 ug | 493.2 EUR |
Glypican 3 (GPC3) Antibody |
|||
abx028330-400ul | Abbexa | 400 ul | 627.6 EUR |
Glypican 3 (GPC3) Antibody |
|||
abx028330-80l | Abbexa | 80 µl | 343.2 EUR |
Glypican 3 (GPC3) Antibody |
|||
20-abx225197 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx327568 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
abx233512-100ug | Abbexa | 100 ug | 577.2 EUR |
Glypican 3 (GPC3) Antibody |
|||
abx233513-100ug | Abbexa | 100 ug | 661.2 EUR |
Glypican 3 (GPC3) Antibody |
|||
20-abx172655 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx172656 | Abbexa |
|
|
Glypican 3 (GPC3) Antibody |
|||
20-abx176683 | Abbexa |
|
|
Rat Glypican-3 (Gpc3) |
|||
1-CSB-YP009705RA | Cusabio |
|
|
Description: Recombinant Rat Glypican-3(Gpc3),partial expressed in Yeast |
|||
glypican-3(GPC3)Antigen |
|||
E62C02801 | EnoGene | 20ug | 458.4 EUR |
Recombinant Glypican 3 (GPC3) |
|||
4-RPA971Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Glypican 3 expressed in: E.coli |
|||
Recombinant Glypican 3 (GPC3) |
|||
4-RPA971Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Glypican 3 expressed in: E.coli |
|||
Glypican 3 Antibody (GPC3) |
|||
F49599-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Glypican 3 Antibody (GPC3) |
|||
F49600-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Glypican 3 Antibody (GPC3) |
|||
F49601-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Glypican 3 Antibody / GPC3 |
|||
V2536-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2536-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2536IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2536SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2537-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2537-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2537CF555-100T | NSJ Bioreagents | 100 Tests | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilms tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2537IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2537SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2538-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2538-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2538IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V2538SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V3270-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V3270-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V3270SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V3714-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V3714-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V3714IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V3714SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V3715-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V3715-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V3715IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V3715SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7027-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7027-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7027IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7027SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7261-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7261-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7261IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V7261SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
|||
Glypican 3 Antibody / GPC3 |
|||
V4020-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V4020-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Glypican 3 Antibody / GPC3 |
|||
V4020SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
|||
Human Glypican 3 (GPC3) Protein |
|||
abx060155-100ug | Abbexa | 100 ug | 1362 EUR |
Human Glypican 3 (GPC3) Protein |
|||
abx060263-1mg | Abbexa | 1 mg | 2532 EUR |
Human Glypican 3 (GPC3) Protein |
|||
20-abx066892 | Abbexa |
|
|
GPC3 ELISA Kit| Mouse Glypican 3 ELISA Kit |
|||
EF013651 | Lifescience Market | 96 Tests | 826.8 EUR |
GPC3 ELISA Kit| Rat Glypican 3 ELISA Kit |
|||
EF017775 | Lifescience Market | 96 Tests | 826.8 EUR |
ELISA kit for Rat GPC3 (Glypican 3) |
|||
E-EL-R0974 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Rat GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Rat GPC3 (Glypican 3) |
|||
ELK4296 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Glypican 3 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
ELISA kit for Mouse GPC3 (Glypican 3) |
|||
E-EL-M0328 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Mouse GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
|||
CLIA kit for Human GPC3 (Glypican 3) |
|||
E-CL-H1076 | Elabscience Biotech | 1 plate of 96 wells | 700.8 EUR |
Description: A sandwich CLIA kit for quantitative measurement of Human GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
|||
Mouse Glypican 3 (GPC3) CLIA Kit |
|||
abx195536-96tests | Abbexa | 96 tests | 990 EUR |
Rat Glypican 3 (GPC3) CLIA Kit |
|||
abx195537-96tests | Abbexa | 96 tests | 990 EUR |
Rat Glypican 3 (GPC3) CLIA Kit |
|||
20-abx492280 | Abbexa |
|
|
Glypican 3 (GPC3) Monoclonal Antibody (Human) |
|||
4-MAA971Hu22 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3) |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human) |
|||
4-PAA971Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3) |
|||
GPC3 Glypican-3 Human Recombinant Protein |
|||
PROTP51654 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: GPC3 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 544 amino acids (25-559a.a.) and having a molecular mass of 61.8kDa (Molecular size on SDS-PAGE will appear at approximately 50-70kDa). GPC3 is expressed with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques. |
|||
Anti-Glypican 3/GPC3 Antibody |
|||
A01922-2 | BosterBio | 100ug/vial | 352.8 EUR |
Glypican 3 / GPC3 Recombinant Protein |
|||
11-400 | ProSci | 0.1 mg | 682.8 EUR |
Description: Glypican-3 (GPC3) is also known as Intestinal protein OCI-5, GTR2-2, MXR7, which belongs to the glypican family. Glypican 3 / GPC-3 is highly expressed in lung, liver and kidney. Glypican-3 inhibits the dipeptidyl peptidase activity of DPP4. Glypican-3 may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and also may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. |
|||
Mouse Glypican 3 (GPC3) Protein |
|||
20-abx167236 | Abbexa |
|
|
Rat Glypican 3 (GPC3) Protein |
|||
20-abx653617 | Abbexa |
|
|
Glypican-3(GPC3/863) Antibody |
|||
BNC040863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC040863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC050863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC050863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Pan troglodytes Glypican-3 (GPC3) |
|||
1-CSB-MP009705EQV | Cusabio |
|
|
Description: Recombinant Pan troglodytes Glypican-3 (GPC3) expressed in Mammalian cell |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCAP0863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCAP0863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCB0863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCB0863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCP0863-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCR0863-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), RPE conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC940863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC940863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCA0863-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), APC conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC810863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC810863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNUB0863-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Concentration: 0.2mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNUB0863-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Concentration: 0.2mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCH0863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNCH0863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC880863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC880863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC680863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC680863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC470863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC470863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC400863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC400863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC430863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC430863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC550863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC550863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC610863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC610863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC800863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC800863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC700863-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNC700863-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3(GPC3/863) Antibody |
|||
BNUM0863-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against Glypican-3(GPC3/863), 1mg/mL |
|||
Human CellExp? Glypican 3 / GPC3, Human recombinant |
|||
P1057-10 | Biovision | each | 170.4 EUR |
Human CellExp? Glypican 3 / GPC3, Human recombinant |
|||
P1057-50 | Biovision | each | 483.6 EUR |
CLIA kit for Mouse GPC3 (Glypican 3) |
|||
E-CL-M0219 | Elabscience Biotech | 1 plate of 96 wells | 700.8 EUR |
Description: A sandwich CLIA kit for quantitative measurement of Mouse GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
|||
CLIA kit for Rat GPC3 (Glypican 3) |
|||
E-CL-R0646 | Elabscience Biotech | 1 plate of 96 wells | 700.8 EUR |
Description: A sandwich CLIA kit for quantitative measurement of Rat GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
|||
Glypican 3 (GPC3) Monoclonal Antibody (Human), APC |
|||
4-MAA971Hu22-APC | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with APC. |
|||
Glypican 3 (GPC3) Monoclonal Antibody (Human), Biotinylated |
|||
4-MAA971Hu22-Biotin | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with Biotin. |
|||
Glypican 3 (GPC3) Monoclonal Antibody (Human), Cy3 |
|||
4-MAA971Hu22-Cy3 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with Cy3. |
|||
Glypican 3 (GPC3) Monoclonal Antibody (Human), FITC |
|||
4-MAA971Hu22-FITC | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with FITC. |
|||
Glypican 3 (GPC3) Monoclonal Antibody (Human), HRP |
|||
4-MAA971Hu22-HRP | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with HRP. |
|||
Glypican 3 (GPC3) Monoclonal Antibody (Human), PE |
|||
4-MAA971Hu22-PE | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with PE. |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human), APC |
|||
4-PAA971Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with APC. |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAA971Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with Biotin. |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human), Cy3 |
|||
4-PAA971Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with Cy3. |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human), FITC |
|||
4-PAA971Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with FITC. |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human), HRP |
|||
4-PAA971Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with HRP. |
|||
Glypican 3 (GPC3) Polyclonal Antibody (Human), PE |
|||
4-PAA971Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Glypican 3 (GPC3). This antibody is labeled with PE. |
|||
Human CellExp? Glypican 3 /GPC3, mouse recombinant |
|||
P1118-10 | Biovision | each | 176.4 EUR |
Human CellExp? Glypican 3 /GPC3, mouse recombinant |
|||
P1118-50 | Biovision | each | 483.6 EUR |
Human CellExp? Glypican 3 / GPC3, Cynomolgus Recombinant |
|||
P1176-10 | Biovision | each | 222 EUR |
Human CellExp? Glypican 3 / GPC3, Cynomolgus Recombinant |
|||
P1176-50 | Biovision | each | 874.8 EUR |
Human CellExp? Glypican 3 / GPC3, Mouse Recombinant |
|||
P1177-10 | Biovision | each | 196.8 EUR |
Human CellExp? Glypican 3 / GPC3, Mouse Recombinant |
|||
P1177-50 | Biovision | each | 652.8 EUR |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC041534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF405S conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC041534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF405S conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCAP1534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCAP1534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCH1534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCH1534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCP1534-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),PerCP conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCR1534-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),RPE conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC941534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC941534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCA1534-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),APC conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC811534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF680R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC811534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF680R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNUB1534-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), Concentration: 0.2mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNUB1534-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), Concentration: 0.2mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC881534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF488A conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC881534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF488A conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCB1534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Biotin conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNCB1534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Biotin conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC611534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF660R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC611534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF660R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC681534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF568 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC681534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF568 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC431534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF543 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC431534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF543 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC471534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF647 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC471534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF647 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC401534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF640R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC401534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF640R conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC551534-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF555 conjugate, Concentration: 0.1mg/mL |
|||
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
|||
BNC551534-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF555 conjugate, Concentration: 0.1mg/mL |